96.24 USD
↗ 2.07 (2.20%)AT CLOSE (11:59 AM EDT)
Mirum Pharmaceuticals, Inc. Common Stock
MIRMNASDAQ • USD
96.25
↗ 0.02 (0.02%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
96.25
↗ 0.02 (0.02%)
Market: OPEN
Open?$93.85
High?$96.54
Low?$93.48
Prev. Close?$94.17
Volume?494.3K
Avg. Volume?994.9K
VWAP?$95.67
Rel. Volume?0.50x
Bid / Ask
Bid?$81.88 × 100
Ask?$110.12 × 100
Spread?$28.24
Midpoint?$96.00
Valuation & Ratios
Market Cap?5.7B
Shares Out?60.3M
Float?40.8M
Float %?79.4%
P/E Ratio?N/A
P/B Ratio?18.06
EPS?-$0.39
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.67Strong
Quick Ratio?2.55Strong
Cash Ratio?1.44Strong
Debt/Equity?0.98Moderate
ValuationRICHLY VALUED
Score33/100
P/E?N/A▾
P/B?18.06HIGH▾
P/S?10.90HIGH▾
P/FCF?103.6PRICEY▾
EV/EBITDA?2,701.8HIGH▾
EV/Sales?10.93HIGH▾
Returns & Efficiency
ROE?-7.4%WEAK▾
ROA?-2.8%WEAK▾
Cash Flow & Enterprise
FCF?$54.9M
Enterprise Value?$5.7B
Related Companies
Loading...
News
Profile
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Employees
372
Market Cap
5.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-07-18
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404
Phone: 650-667-4085
FOSTER CITY, CA 94404
Phone: 650-667-4085